We are live on ! Find out more
PXS icon

Pyxis Tankers

5 hedge funds and large institutions have $70K invested in Pyxis Tankers in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

31,697% more capital inflows, than outflows

Capital inflows: $78.5K | Capital outflows: $247

67% more funds holding

Funds holding: 3 → 5 (+2)

0.17% more ownership

Funds ownership: 0% → 0.17% (+0.17%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Sellers

Rank Fund Capital Flow
1
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$247

PXS Hedge Fund Activity: Q1 2017 in Review

5 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Pyxis Tankers (PXS) for Q1 2017, worth a combined $70K — up 6,900% from $1K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PXS positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Spark Investment Management, opening a new position worth an estimated $38.5K. The largest seller was Tower Research Capital (TRC), cutting an estimated $247.

  • 5 institutional investors held Pyxis Tankers (PXS) as of Q1 2017, up from 3 in Q4 2016.
  • Funds reported $70K of Pyxis Tankers stock for Q1 2017, up 6,900% quarter-over-quarter.
  • 3 funds opened new Pyxis Tankers positions in Q1 2017 and 0 closed out, a net change of +3 holders.
  • The largest Pyxis Tankers buyer in Q1 2017 was Spark Investment Management, an estimated $38.5K added.
  • The largest Pyxis Tankers seller in Q1 2017 was Tower Research Capital (TRC), an estimated $247 sold.

Based on aggregated 13F filings for Q1 2017.